BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 18072496)

  • 1. Realtime light dosimetry software tools for interstitial photodynamic therapy of the human prostate.
    Johansson A; Axelsson J; Andersson-Engels S; Swartling J
    Med Phys; 2007 Nov; 34(11):4309-21. PubMed ID: 18072496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transperineal in vivo fluence-rate dosimetry in the canine prostate during SnET2-mediated PDT.
    Lilge L; Pomerleau-Dalcourt N; Douplik A; Selman SH; Keck RW; Szkudlarek M; Pestka M; Jankun J
    Phys Med Biol; 2004 Jul; 49(14):3209-25. PubMed ID: 15357193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. System for interstitial photodynamic therapy with online dosimetry: first clinical experiences of prostate cancer.
    Swartling J; Axelsson J; Ahlgren G; Kälkner KM; Nilsson S; Svanberg S; Svanberg K; Andersson-Engels S
    J Biomed Opt; 2010; 15(5):058003. PubMed ID: 21054129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Light dosimetry for multiple cylindrical diffusing sources for use in photodynamic therapy.
    Dickey DJ; Partridge K; Moore RB; Tulip J
    Phys Med Biol; 2004 Jul; 49(14):3197-208. PubMed ID: 15357192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spatial distribution of liposome encapsulated tin etiopurpurin dichloride (SnET2) in the canine prostate: implications for computer simulation of photodynamic therapy.
    Aniola J; Selman SH; Lilge L; Keck R; Jankun J
    Int J Mol Med; 2003 Mar; 11(3):287-91. PubMed ID: 12579328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of source batch S dispersion on dosimetry for prostate cancer treatment with permanent implants.
    Nuñez-Cumplido E; Perez-Calatayud J; Casares-Magaz O; Hernandez-Armas J
    Med Phys; 2015 Aug; 42(8):4933-40. PubMed ID: 26233219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment planning and dose analysis for interstitial photodynamic therapy of prostate cancer.
    Davidson SR; Weersink RA; Haider MA; Gertner MR; Bogaards A; Giewercer D; Scherz A; Sherar MD; Elhilali M; Chin JL; Trachtenberg J; Wilson BC
    Phys Med Biol; 2009 Apr; 54(8):2293-313. PubMed ID: 19305043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The physics, biophysics and technology of photodynamic therapy.
    Wilson BC; Patterson MS
    Phys Med Biol; 2008 May; 53(9):R61-109. PubMed ID: 18401068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of uterine cervix shape on photodynamic therapy efficiency.
    Bednarkiewicz A; Strek W
    J Biomed Opt; 2004; 9(5):1013-7. PubMed ID: 15447023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adaptation of the CVT algorithm for catheter optimization in high dose rate brachytherapy.
    Poulin E; Fekete CA; Létourneau M; Fenster A; Pouliot J; Beaulieu L
    Med Phys; 2013 Nov; 40(11):111724. PubMed ID: 24320432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laser dosimetry studies in the prostate.
    Chen Q; Hetzel FW
    J Clin Laser Med Surg; 1998 Feb; 16(1):9-12. PubMed ID: 9728124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coverage optimized planning: probabilistic treatment planning based on dose coverage histogram criteria.
    Gordon JJ; Sayah N; Weiss E; Siebers JV
    Med Phys; 2010 Feb; 37(2):550-63. PubMed ID: 20229863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of in vivo light fluence distribution in a heterogeneous prostate during photodynamic therapy.
    Li J; Zhu TC
    Phys Med Biol; 2008 Apr; 53(8):2103-14. PubMed ID: 18369279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Online dosimetry for temoporfin-mediated interstitial photodynamic therapy using the canine prostate as model.
    Swartling J; Höglund OV; Hansson K; Södersten F; Axelsson J; Lagerstedt AS
    J Biomed Opt; 2016 Feb; 21(2):28002. PubMed ID: 26886806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance of a dedicated light delivery and dosimetry device for photodynamic therapy of nasopharyngeal carcinoma: phantom and volunteer experiments.
    Nyst HJ; van Veen RL; Tan IB; Peters R; Spaniol S; Robinson DJ; Stewart FA; Levendag PC; Sterenborg HJ
    Lasers Surg Med; 2007 Sep; 39(8):647-53. PubMed ID: 17886277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IMRT: improvement in treatment planning efficiency using NTCP calculation independent of the dose-volume-histogram.
    Grigorov GN; Chow JC; Grigorov L; Jiang R; Barnett RB
    Med Phys; 2006 May; 33(5):1250-8. PubMed ID: 16752559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "SABER": A new software tool for radiotherapy treatment plan evaluation.
    Zhao B; Joiner MC; Orton CG; Burmeister J
    Med Phys; 2010 Nov; 37(11):5586-92. PubMed ID: 21158270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A heterogeneous algorithm for PDT dose optimization for prostate.
    Altschuler MD; Zhu TC; Hu Y; Finlay JC; Dimofte A; Wang K; Li J; Cengel K; Malkowicz SB; Hahn SM
    Proc SPIE Int Soc Opt Eng; 2009 Feb; 7164():71640B. PubMed ID: 25914793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Light dosimetry for intraperitoneal photodynamic therapy in a murine xenograft model of human epithelial ovarian carcinoma.
    Lilge L; Molpus K; Hasan T; Wilson BC
    Photochem Photobiol; 1998 Sep; 68(3):281-8. PubMed ID: 9747583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimized interstitial PDT prostate treatment planning with the Cimmino feasibility algorithm.
    Altschuler MD; Zhu TC; Li J; Hahn SM
    Med Phys; 2005 Dec; 32(12):3524-36. PubMed ID: 16475751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.